92 related articles for article (PubMed ID: 12777194)
21. [Progress of adjuvant chemotherapy in colon cancer].
Toge T
Gan To Kagaku Ryoho; 1996 Apr; 23(5):554-9. PubMed ID: 8678512
[TBL] [Abstract][Full Text] [Related]
22. [Effective not only in rheumatism and arthrosis. Rofecoxib fights also acute pain].
MMW Fortschr Med; 2002 Feb; 144(7):68. PubMed ID: 11887740
[No Abstract] [Full Text] [Related]
23. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
[TBL] [Abstract][Full Text] [Related]
24. Why don't we initiate more large simple randomized controlled trials?
Wright JM
CMAJ; 2003 Nov; 169(11):1170-1. PubMed ID: 14638653
[No Abstract] [Full Text] [Related]
25. Treatment of colorectal cancer.
Påhlman L
Ann Chir Gynaecol; 2000; 89(3):216-20. PubMed ID: 11079791
[No Abstract] [Full Text] [Related]
26. [Rofecoxib].
Cárdenas E; Barasoain A; Honorato J
Rev Med Univ Navarra; 2001; 45(2):60-3. PubMed ID: 11764701
[No Abstract] [Full Text] [Related]
27. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.
Ehrich EW; Davies GM; Watson DJ; Bolognese JA; Seidenberg BC; Bellamy N
J Rheumatol; 2000 Nov; 27(11):2635-41. PubMed ID: 11093446
[TBL] [Abstract][Full Text] [Related]
28. [New anti-inflammatory analgetics--are they needed?].
Paakkari I
Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925
[No Abstract] [Full Text] [Related]
29. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
[TBL] [Abstract][Full Text] [Related]
30. [Cox-2 inhibitors in the focus. Rofecoxib as effective as the "classics"].
MMW Fortschr Med; 2001 Nov; 143(46):50-1. PubMed ID: 11759601
[No Abstract] [Full Text] [Related]
31. [Progress in adjuvant therapy for colorectal cancer].
Kohnoe S; Kakeji Y; Maehara Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2488-97. PubMed ID: 12506471
[TBL] [Abstract][Full Text] [Related]
32. COX-2-specific inhibition: implications for clinical practice.
Pascucci RA
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S18-22. PubMed ID: 10643177
[TBL] [Abstract][Full Text] [Related]
33. [Following curative resection of colorectal cancer, portal chemotherapy especially benefits non-transfused patients].
Harder F; Laffer U; Berres M; Jäggi P; Metzger U
Chirurg; 1990 Apr; 61(4):280-5. PubMed ID: 2112083
[TBL] [Abstract][Full Text] [Related]
34. [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].
Krankenpfl J; 2004; 42(7-10):234. PubMed ID: 15675396
[No Abstract] [Full Text] [Related]
35. Clinical trials. Nail-biting time for trials of COX-2 drugs.
Couzin J
Science; 2004 Dec; 306(5702):1673-5. PubMed ID: 15576585
[No Abstract] [Full Text] [Related]
36. [Initial results of adjuvant portal liver infusion following radical surgery of colorectal cancer (Swiss Study Group for Epidemiologic and Clinical Cancer Research Study 40/81)].
Metzger U; Laffer U; Egeli R; Barras J; Martinoli S; Müller W; Arma S; Bär HU; Schweizer W; Aeberhard P
Helv Chir Acta; 1989 Dec; 56(4):455-60. PubMed ID: 2517282
[TBL] [Abstract][Full Text] [Related]
37. [General practice study of therapy of acute pain. Patients prefer cox-2 inhibitors].
MMW Fortschr Med; 2004 May; 146(21):61. PubMed ID: 15373091
[No Abstract] [Full Text] [Related]
38. [The CLASS study and its scientific statement. Ethical publishing rules neglected].
Wollheim FA
Lakartidningen; 2002 Oct; 99(40):3934-5. PubMed ID: 12422748
[No Abstract] [Full Text] [Related]
39. [New indication for selective COX-2 inhibitors. Now also approve for acute pain].
MMW Fortschr Med; 2002 Mar; 144(10):62. PubMed ID: 11928272
[No Abstract] [Full Text] [Related]
40. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
